• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Alexza Pharmaceuticals Inc

+ Add to Watchlist

N3VN:GR

1.124 EUR 0.070 5.86%

As of 15:14:45 ET on 12/23/2014.

Snapshot for Alexza Pharmaceuticals Inc (N3VN)

Open: 1.173 Day's Range: 1.124 - 1.208 Volume: 0
Previous Close: 1.194 52wk Range: 0.996 - 4.200 1-Yr Rtn: -67.68%

Stock Chart for N3VN

No chart data available.
  • N3VN:GR 1.165
  • 1D
  • 1M
  • 1Y
1.194
Interactive N3VN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for N3VN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -2.4100
Est. PEG Ratio -
Market Cap (M EUR) 21.81
Shares Outstanding (M) 19.40
30 Day Average Volume 519
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for N3VN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for N3VN

Alexza Pharmaceuticals, Inc. is a pharmaceutical company focused on the development and commercialization of proprietary products for the treatment of acute and intermittent conditions.

Thomas B KingPresident/CEORobert A LippeExec VP:Operations/COO
James V CassellaExec VP:Research & DevMark K OkiSenior VP:Finance/CFO/Secy
More Company Profile & Key Executives for N3VN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil